JOSHUA PROL: Open Payments
NPI 1184294811 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 19 payments from 11 companies in 2025. Trend: 2023 $825 · 2024 $1,304 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 4 | $71 |
| ABBVIE INC. | 3 | $70 |
| Lilly USA, LLC | 3 | $53 |
| Amgen Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: REXULTI, QULIPTA, MOUNJARO, ETERNA, Ozempic, GARDASIL 9, SHINGRIX, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
